KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strategy (MSTR) Gains from Sales and Divestitures (2021 - 2025)

Historic Gains from Sales and Divestitures for Strategy (MSTR) over the last 5 years, with Q3 2025 value amounting to $371000.0.

  • Strategy's Gains from Sales and Divestitures fell 1331.78% to $371000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $371000.0, marking a year-over-year decrease of 1331.78%. This contributed to the annual value of $571000.0 for FY2024, which is 5643.84% up from last year.
  • As of Q3 2025, Strategy's Gains from Sales and Divestitures stood at $371000.0, which was down 1331.78% from $334000.0 recorded in Q2 2025.
  • In the past 5 years, Strategy's Gains from Sales and Divestitures registered a high of $571000.0 during Q4 2024, and its lowest value of $4000.0 during Q1 2022.
  • In the last 5 years, Strategy's Gains from Sales and Divestitures had a median value of $37000.0 in 2024 and averaged $170866.7.
  • As far as peak fluctuations go, Strategy's Gains from Sales and Divestitures surged by 215263.16% in 2024, and later crashed by 1331.78% in 2025.
  • Quarter analysis of 5 years shows Strategy's Gains from Sales and Divestitures stood at $17000.0 in 2021, then skyrocketed by 1558.82% to $282000.0 in 2022, then rose by 29.43% to $365000.0 in 2023, then soared by 56.44% to $571000.0 in 2024, then plummeted by 35.03% to $371000.0 in 2025.
  • Its Gains from Sales and Divestitures stands at $371000.0 for Q3 2025, versus $334000.0 for Q2 2025 and $104000.0 for Q1 2025.